Loncar Cancer Immunotherapy ETF’s (CNCR) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Loncar Cancer Immunotherapy ETF is a Sell.
Loncar Cancer Immunotherapy ETF’s (CNCR) 20-Day exponential moving average is 12.41, making it a Sell.
Loncar Cancer Immunotherapy ETF’s (CNCR) 50-Day exponential moving average is 12.67, making it a Sell.